[1]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2019/212991,2019,A1Locationinpatent:Paragraph00588
[1]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2019/212991,2019,A1
[2]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2021/257736,2021,A1
[1]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2019/212991,2019,A1
[2]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2019/212990,2019,A1
[3]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2021/257736,2021,A1
[1]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2019/212991,2019,A1
[2]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2019/212990,2019,A1
[3]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2021/257736,2021,A1
[1]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2019/212991,2019,A1
[2]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2019/212990,2019,A1
[3]CurrentPatentAssignee:REVOLUTIONMEDICINESINC-WO2021/257736,2021,A1
Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562